Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy.
Pei-Chien TsaiChung-Feng HuangMing-Lun YehMeng-Hsuan HsiehHsing-Tao KuoChao-Hung HungKuo-Chih TsengHsueh-Chou LaiCheng-Yuan PengJing-Houng WangJyh-Jou ChenPei-Lun LeeRong-Nan ChienChi-Chieh YangGin-Ho LoJia-Horng KaoChun-Jen LiuChen-Hua LiuSheng-Lei YanChun-Yen LinWei-Wen SuCheng-Hsin ChuChih-Jen ChenShui-Yi TungChi-Ming TaiChih-Wen LinChing-Chu LoPin-Nan ChengYen-Cheng ChiuChia-Chi WangJin-Shiung ChengWei-Lun TsaiHan-Chieh LinYi-Hsiang HuangChi-Yi ChenJee-Fu HuangChia-Yen DaiWan-Long ChungMing-Jong BairMing-Lung Yunull nullPublished in: Clinical and molecular hepatology (2024)
Metformin and statins may have a chemopreventive effect against HCC in CHC patients who failed antiviral therapy. These results support the need for personalized preventive strategies in managing HCC risk.